Crohn's Disease and Colitis Trial, Recruiting (NCT07169123)

Crohn's Disease and Colitis Trial, Recruiting NCT07169123 Sponsor: McMaster University Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT07169123 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

People between 18 and 70 years of age.
People who have been diagnosed with Crohn's disease.
People who are willing and able to sign a written consent form before the study begins.
People who, in the opinion of the study doctor, are able to follow the study procedures as required.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who are currently taking, or have taken in the last 8 weeks, antibiotics, antibacterial medications, or probiotics.
People with a history of alcohol or drug abuse.
People who are pregnant.
People who have other ongoing health conditions or abnormal lab results that the study doctors consider a risk to the person or that could affect the study results (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: David Armstrong, MD, McMaster University

Phone: 905 521-2100

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07169123

Sponsor: McMaster University

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 905 521-2100

More information: https://clinicaltrials.gov/study/NCT07169123

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who may be able to join

People between 18 and 70 years of age.
People who have been diagnosed with Crohn's disease.
People who are willing and able to sign a written consent form before the study begins.
People who, in the opinion of the study doctor, are able to follow the study procedures as required.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

People who are currently taking, or have taken in the last 8 weeks, antibiotics, antibacterial medications, or probiotics.
People with a history of alcohol or drug abuse.
People who are pregnant.
People who have other ongoing health conditions or abnormal lab results that the study doctors consider a risk to the person or that could affect the study results (confirm with trial site).

Important: Always verify eligibility with the trial site directly before applying."

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

McMaster University

Registry

ClinicalTrials.gov

Start date

18 September 2025

Est. completion

1 September 2029

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Dietary Sodium Intake

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov

Who may and may not be able to join

Who may be able to join

Who may not be able to join

Contact this trial

GP referral letter

Who may be able to join

Who may not be able to join

Trial details

Where this trial is recruiting

Primary endpoints

Can't join this trial?

Expanded access pathways

Other trials for Crohn's Disease and Colitis